Earnings Estimates Moving Higher for Healthstream (HSTM): Time to Buy? – Tale of the Tape

Zacks

Healthstream Inc. (HSTM) is a healthcare software services provider that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.

These positive earnings estimate revisions suggest that analysts are becoming more optimistic on HSTM’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Healthstream could be a solid choice for investors.

Current Quarter Estimates for HSTM

In the past 30 days, 2 estimates have gone higher for Healthstream while 1 has gone lower in the same time period. The trend has been pretty favorable too, with estimates increasing from 4 cents a share 30 days ago, to 6 cents today, a move of 50%.

Current Year Estimates for HSTM

Meanwhile, Healthstream’s current year figures are also looking quite promising, with 4 estimates moving higher in the past month, compared to no downward revision. The consensus estimate trend has also seen a boost for this time frame, increasing/narrowing from 22 cents per share 30 days ago to 32 cents per share today, an increase of 45.5%.

Bottom Line

The stock has also started to move higher lately, adding 12.6% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #1 (Strong Buy) stock to profit in the near future.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research

Be the first to comment

Leave a Reply